Does the NHS pay for MACI?

NHS funding for MACI does exist — but it is conditional, not automatic. Under NICE Technology Appraisal TA477, published in October 2017, commissioners are legally obligated to fund autologous chondrocyte implantation (ACI), which encompasses MACI, when a patient satisfies all defined eligibility criteria. Because this is a technology appraisal rather than an advisory guideline, the funding obligation is binding: an Integrated Care Board cannot simply decline to commission the procedure if every criterion is met.

For Lincolnshire patients, two further hurdles sit between a positive eligibility decision and an operation. First, Lincolnshire ICB's Prior Approval Policy (CG 003, updated April 2025) requires the ICB to grant approval before any referral to a tertiary centre can proceed — this is not a straightforward GP-to-specialist pathway. Second, MACI must be performed at a specialist NHS tertiary referral centre; no such centre exists within Lincolnshire itself, meaning patients will travel, most likely to the Robert Jones and Agnes Hunt Orthopaedic Hospital (RJAH) in Oswestry or to the Royal National Orthopaedic Hospital (RNOH) in Stanmore. Where the local ICB does not hold an established direct commissioning route for MACI specifically, the treating clinician may need to pursue an Individual Funding Request (IFR) as the access pathway.

The eligibility criteria that determine whether that funding obligation is triggered are covered in the next section.

Who qualifies under NICE criteria

Four criteria determine whether the TA477 funding obligation is triggered, and all four must be satisfied simultaneously — partial qualification does not unlock funding.

1. No previous cartilage repair surgery in the same knee. A single prior microfracture is a categorical exclusion. Marrow-stimulation procedures alter the subchondral bone plate, making subsequent MACI technically more demanding and outcomes less predictable; NICE draws a hard line rather than a spectrum.
2. Minimal or absent osteoarthritis. MACI addresses focal, discrete cartilage loss in an otherwise preserved joint. Where osteoarthritis is established or widespread — the clinical picture often described as 'bone on bone' — the biological environment cannot support regeneration. Patients in this category are outside the cartilage-repair window altogether and require a different clinical conversation.
3. A symptomatic focal full-thickness defect greater than 2 cm². Smaller defects fall below the NICE threshold. For lesions under approximately 2–4 cm², other techniques such as mosaicplasty remain reasonable alternatives; the SUMMIT trial, which informed the TA477 evidence base, specifically demonstrated MACI's advantage over microfracture for defects of 3 cm² or larger.
4. The procedure must be performed at an NHS tertiary referral centre by experienced clinicians. This is not discretionary — the centre requirement is written into the funding condition.

Before any surgical route is considered, conservative management must be fully exhausted: structured physiotherapy, analgesics, and appropriate exercise programmes come first. Clinicians and commissioners will expect documented evidence that this pathway has been followed.

How Lincolnshire patients reach an NHS MACI centre

Reaching an NHS MACI centre from Lincolnshire involves several distinct steps, each of which must be completed before the next opens.

1. GP assessment. The first formal step is a GP appointment to document symptoms and exclude red-flag pathology. The GP may initiate imaging and will refer into the community MSK pathway.
2. Community MSK service and physiotherapy. Conservative management — structured exercise, physiotherapy, analgesics — must be fully exhausted and documented before any surgical route is considered.
3. Local orthopaedic consultant. If conservative care has not resolved symptoms and MACI eligibility looks plausible, the local consultant conducts specialist assessment, typically including MRI, and determines whether the TA477 criteria are likely met.
4. ICB prior-approval request. This is a mandatory gate, not a routine referral step. Under Lincolnshire ICB Prior Approval Policy CG 003 (updated April 2025), the treating orthopaedic consultant must submit a prior-approval application to the ICB; the ICB then confirms that funding criteria are met before authorising the onward referral.
5. Tertiary centre referral via Lincolnshire EACH. Elective referrals are coordinated through the Lincolnshire Elective Activity Coordination Hub (EACH), which offers patients a minimum of five provider choices including private providers delivering NHS-funded care, with clinical triage determining the appropriate setting.

The three principal NHS ACI/MACI centres in England are RJAH (Oswestry), RNOH Stanmore — which has performed over 1,500 cartilage transplantation cases — and University Hospital Southampton. For most Lincolnshire patients, RJAH is the geographically closest; its teams have offered ACI for over 20 years. Because MACI is a two-stage procedure with a four-to-six-week laboratory interval between operations, travelling to Oswestry on two separate occasions is a practical planning consideration worth raising early.

Waiting times vary significantly by centre and change over time; the local orthopaedic consultant is the most reliable source for a current estimate at the point of referral.

When an Individual Funding Request applies

The IFR route applies in a specific circumstance: when MACI specifically — rather than the broader ACI category — falls outside an ICB's established commissioning policy, so that prior approval alone cannot unlock funding. Where that gap exists, a separate funding exception mechanism is needed.

An Individual Funding Request (IFR) or Exceptional Funding Request (EFR) can only be submitted by the treating clinician, not the patient. The submission must satisfy two tests: that this patient's clinical circumstances are significantly different from the general population with the same condition, and that the procedure is likely to produce exceptional benefit beyond what the average patient would expect. Both must be argued on clinical grounds; a general case for MACI's effectiveness is not sufficient.

The prior-approval process under Lincolnshire ICB Policy CG 003 and an IFR are not interchangeable. Prior approval is a commissioning gate — the ICB confirming that standard TA477 criteria are met. An IFR is a funding exception request for cases where the standard pathway does not straightforwardly apply. Some patients assume an IFR is always required; others assume it is straightforward once submitted. Neither is reliably true.

IFR approval rates for MACI specifically within NHS Lincolnshire ICB are not publicly reported. Before any application is prepared, asking the treating consultant to set out the clinical reasoning and the realistic strength of the case is a practical first step.

Private MACI in Lincolnshire: what it costs and where to go

The cost figures that most patients encounter online — and the ones that apply here — are national estimates, not confirmed quotes from any specific Lincolnshire provider. With that caveat stated plainly: private MACI in the UK is typically priced at approximately £25,000–£35,000 all-inclusive as of 2026, according to London Cartilage Clinic pricing data. The NICE costing model lists the MACI collagen membrane implant alone at roughly £16,000; laboratory cell-culturing between the two operations adds a further £10,000 or more on top of that. Neither figure includes surgeon fees, anaesthetic, theatre time, post-operative imaging, or physiotherapy — costs that accumulate across both stages.

The mandatory two-stage structure is the principal reason MACI sits at the higher end of cartilage repair pricing. Stage one (arthroscopic biopsy harvest) and stage two (open implantation, four to six weeks later) each carry their own facility and professional fees. Single-stage alternatives — such as AMIC or osteochondral autograft (OATS) — avoid the laboratory interval entirely, which substantially reduces overall cost. Patients weighing private options should ask any provider for an itemised two-stage quote rather than a single headline figure.

Local private options in Lincolnshire

For initial cartilage assessment and pathway navigation, the Lincolnshire Knee Clinic at MSK House, Sleaford (NG34) has a consultant cartilage surgeon with ACI/MACI pathway experience and onsite MRI — including AI-assisted cartilage analysis — which can support staging and treatment planning. Patients considering MACI should ask specifically about the surgeon's ACI/MACI caseload, not only general orthopaedic experience, since the procedure is technically demanding and volume matters for outcomes. Circle Health Group's Lincoln Private Hospital is a further local option for orthopaedic assessment and surgery. Ramsay Health Care's Boston West Hospital in Boston offers knee arthroscopy on self-pay packages and may be relevant at the diagnostic or first-stage level.

For the full two-stage MACI procedure itself, patients frequently need to travel to regional specialist centres in Nottingham, Sheffield, or London through networks such as Spire Healthcare or Nuffield Health. Private medical insurance (Bupa, AXA Health) may cover MACI subject to individual policy terms — worth checking before committing to self-pay.

Other cartilage repair routes for patients who do not fit MACI

Not every patient who reads this article will be a MACI candidate — and for those excluded by prior surgery, defect size, or the degree of joint wear, meaningful cartilage repair options still exist.

For focal defects where marrow stimulation is appropriate, AMIC (autologous matrix-induced chondrogenesis) combines microfracture with a resorbable scaffold to support chondrogenesis in a single-stage procedure, avoiding the laboratory interval and cost of two-stage cell-based repair. For smaller focal defects — roughly 1–2 cm², or up to approximately 4 cm² in mosaic configuration — OATS (osteochondral autograft transfer, also called mosaicplasty) transplants healthy osteochondral plugs from a non-load-bearing area of the same knee in a single operation.

For suitable focal defects, a further pathway is the ChondroFiller injection — an ultrasound-guided outpatient injectable collagen scaffold that works by matrix-induced chondrogenesis, recruiting the patient's own progenitor cells into the scaffold without surgery. This is a current service pathway at Lincolnshire Knee in Sleaford.

Where the underlying problem is established osteoarthritis rather than a discrete focal defect, cartilage repair techniques — including MACI — are outside scope. The appropriate conversation in that situation shifts to alignment correction (osteotomy) or, in end-stage disease, joint replacement.

Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral. An assessment at the Sleaford clinic, with onsite MRI, can help clarify which pathway — if any — fits your knee. Book at lincolnshireknee.co.uk.